Tezuka, K., Takashima, T., Kashiwagi, S., Kawajiri, H., Tokunaga, S., Tei, S., . . . Hirakawa, K. (2017). Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer. Mol Clin Oncol.
Dyfyniad Arddull ChicagoTezuka, Kenji, et al. "Phase I Study of Nanoparticle Albumin-bound Paclitaxel, Carboplatin and Trastuzumab in Women With Human Epidermal Growth Factor Receptor 2-overexpressing Breast Cancer." Mol Clin Oncol 2017.
Dyfyniad MLATezuka, Kenji, et al. "Phase I Study of Nanoparticle Albumin-bound Paclitaxel, Carboplatin and Trastuzumab in Women With Human Epidermal Growth Factor Receptor 2-overexpressing Breast Cancer." Mol Clin Oncol 2017.